Comparison of Supervised Ground Walk Training and Treadmill Walk Training in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial

— GWT/TWT  

Official title:

Phase 0 Study of Comparison Between Ground Walk Training and Treadmill Walk Training in COPD Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02218918
• Other study ID #: PSG01Rehab
• Status: Completed
• Phase: N/A
• First received: August 11, 2014
• Last updated: October 19, 2017
• Start date: July 2014
• Est. completion date: October 2016

Study information

• Verified date: October 2017
• Source: PSG Hospitals
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Pulmonary Rehabilitation became a vital part of management in COPD patients in form of activity modification, dietary and pharmacological optimisation. But access to traditional supervised aerobic (treadmill) walking is debatable fact due to economical and staffing expertise in developing countries like India. The investigators designed a randomised controlled trial to evaluate the effectiveness of ground based walking over traditional treadmill walking in improving quality of life in COPD patients.

Description:

Background: COPD is increasing mortality and morbidity globally. Pulmonary rehabilitation is a promising management in COPD management. Exercise training in form of aerobic (walking, cycling) and strength training is an important part of pulmonary rehabilitation. However access to traditional supervised exercise programs is questionable debate even in developed western countries. Unsupervised ground walk programs are often told by physicians but not properly prescribed.

Objective: To assess whether ground or treadmill walk is better in improving functional capacity and quality of life in COPD patients Design: Randomised controlled trial Procedure: Two arms 1) supervised ground walk training 2) supervised treadmill walk training. The intensity and progression of walk is based on 6 minute walk test. Quality of life will be gauged through Chronic respiratory questionnaire and functional capacity through 6 minute walk test.

Statistical analysis: Descriptive analysis for characterisation. Normality though Kolmogorov and Variables will be compared through paired and unpaired student t tests

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: October 2016
• Est. primary completion date: August 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 70 Years

Eligibility

Inclusion Criteria:

• stable COPD

• Stage II - IV

• Both genders

Exclusion Criteria:

• Cardiovascular diseases uncompensated

• uncompensated pleural diseases

• uncompensated liver diseases

• Recent surgeries less than 3 weeks

• malignancy receiving chemo and radiotherapy

• Recent exacerbations less than 3 months

Related Conditions & MeSH terms

• Chronic Obstructive Pulmonary Disease (COPD)
• Lung Diseases
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Behavioral:
• Ground walk training
3 times a week and 6 weeks
• Supervised Treadmill Walk training
3 times a week and 6 weeks

Locations

Country	Name	City	State
India	PSG Hospitals	Coimbatore	Tamilnadu

Sponsors (1)

Lead Sponsor	Collaborator
PSG Hospitals

Country where clinical trial is conducted

India, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Functional Capacity (6 MINUTE WALK TEST)	6 minute walk test according to standardisation of ATS	Baseline, 6 weeks
Primary	Quality of Life (Chronic Respiratory Questionnaire)	CRQ - interviewer based	Baseline, 6 weeks